Suppl. Figure 1 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Riley A. Hampsch
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
72Publications signalées
269Citations signalées
0Affiliations récentes
Les domaines associés
Cancer, Hypoxia, and MetabolismEstrogen and related hormone effectsRetinoids in leukemia and cellular processesCancer, Lipids, and MetabolismMetabolism, Diabetes, and Cancer
Les publications récentes
Suppl. Figure 2 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 9 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 11 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 6 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Suppl. Figure 6 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 8 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 12 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Suppl. Figure 4 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 7 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 3 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
Supplementary Table 1 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Steven Tau, Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.